<DOC>
	<DOCNO>NCT02906137</DOCNO>
	<brief_summary>The gut immune barrier fully restore HIV-1-infected subject despite receive antiretroviral treatment . This leaky gut lead microbial translocation gut lumen bloodstream fuel deleterious systemic inflammation . The chemotaxis ax allow T lymphocytes migrate blood gut mucosa order reconstitute mucosal immune barrier seem alter treat HIV-1-infected subjects.This study aim well understanding mechanism involve lack mucosal immune restoration .</brief_summary>
	<brief_title>Gut-Associated Lymphocyte Trafficking</brief_title>
	<detailed_description>Pathophysiological study human subject , comparative , national , multicentric prospective . Peripheral blood intestinal biopsy collect .</detailed_description>
	<criteria>Inclusion Criteria : For HIV1infected subject group : Age least 18year old HIV1 infection Receiving continuous cART ≥ 12 month , start chronic phase Plasma viral load ≤50 copies/mL ≥ 6 month ( one blip ≤200 copies/mL authorize ) Blood CD4+ T cell count ≥ 350 cells/mm3 Indication upper and/or lower digestive endoscopy Patient enrol beneficiary Social Security programme ( State Medical Aid AME Social Security programme ) Written informed consent . For uninfected control group : Age least 18year old Indication upper and/or lower digestive endoscopy Patient enrol beneficiary Social Security programme ( State Medical Aid AME Social Security programme ) Written informed consent Exclusion Criteria : For HIV1infected subject group : HIV2 infection Inflammatory bowel disease ( Crohn 's disease , ulcerative colitis ) ; coeliac disease Platelets count &lt; 50 G/L abnormal hemostasis test Decompensated cirrhosis Past current lymphoma Involvement HIV1 immunotherapeutic vaccine study Pregnant breastfeed woman Subjects participate study exclude participate another study Vulnerability , age 18 , tutorship , trusteeship , subject deprive liberty legal administrative decision . For uninfected control group : HIV1 2 infection Inflammatory bowel disease ( Crohn 's disease , ulcerative colitis ) ; coeliac disease Platelets count &lt; 50 G/L abnormal hemostasis test Decompensated cirrhosis Past current lymphoma Pregnant breastfeed woman Subjects participate study exclude participate another study Vulnerability , age 18 , tutorship , trusteeship , subject deprive liberty legal administrative decision</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>